Hiroki Kuniyasu
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer, Hypoxia, and Metabolism 36
- Cancer, Lipids, and Metabolism 16
- Oncology 62
- Cancer-related Molecular Pathways 19
- Co-authors
- Wataru Yasui (56 shared papers)Hiroshi Yokozaki (40 shared papers)Tomonori Sasahira (67 shared papers)Hitoshi Ohmori (94 shared papers)Takamitsu Sasaki (70 shared papers)Kiyomu Fujii (77 shared papers)Isaiah J. Fidler (13 shared papers)Yoshitomo Chihara (20 shared papers)
- Journals
- International Journal of Molecular Sciences (34 papers)Pathobiology (26 papers)Oncotarget (11 papers)Cancer Science (11 papers)International Journal of Cancer (10 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Hiroki Kuniyasu
275 papers receiving 10.8k citations
Peers
Comparison fields: 5 of 129
- Clinical Biochemistry 1.2k
- Cancer Research 1.9k
- Oncology 2.7k
- Molecular Biology 4.8k
- Pathology and Forensic Medicine 893
Countries citing papers authored by Hiroki Kuniyasu
This map shows the geographic impact of Hiroki Kuniyasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kuniyasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kuniyasu more than expected).
Fields of papers citing papers by Hiroki Kuniyasu
This network shows the impact of papers produced by Hiroki Kuniyasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kuniyasu. The network helps show where Hiroki Kuniyasu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Kuniyasu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 281 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. | 1999 | 517 |
| 2 | 1998 | 334 | |
| 3 | 1992 | 302 | |
| 4 | 1999 | 293 | |
| 5 | 2001 | 291 | |
| 6 | 2013 | 245 | |
| 7 | Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. | 2000 | 182 |
| 8 | 2012 | 174 | |
| 9 | Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. | 1995 | 168 |
| 10 | 2003 | 150 | |
| 11 | 2000 | 141 | |
| 12 | 1995 | 131 | |
| 13 | 2003 | 127 | |
| 14 | 2006 | 127 | |
| 15 | 2006 | 125 | |
| 16 | 2000 | 117 | |
| 17 | Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers. | 2000 | 114 |
| 18 | 2005 | 108 | |
| 19 | Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. | 1999 | 106 |
| 20 | 1995 | 104 |
About Hiroki Kuniyasu
Hiroki Kuniyasu is a scholar working on Cancer Research, Oncology, Molecular Biology, Clinical Biochemistry and Biotechnology, having authored 281 papers that have together received 11.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (36 papers), Advanced Glycation End Products research (27 papers), Cancer-related gene regulation (20 papers), Cancer Research and Treatments (19 papers), Cancer-related Molecular Pathways (19 papers), RNA modifications and cancer (18 papers), Cancer, Lipids, and Metabolism (16 papers) and Barrier Structure and Function Studies (15 papers). The work is most often cited by research in Clinical Biochemistry (1.2k citations), Cancer Research (1.9k citations), Oncology (2.7k citations), Molecular Biology (4.8k citations) and Pathology and Forensic Medicine (893 citations). Hiroki Kuniyasu has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Wataru Yasui, Hiroshi Yokozaki, Tomonori Sasahira, Hitoshi Ohmori, Takamitsu Sasaki, Kiyomu Fujii, Isaiah J. Fidler, Yoshitomo Chihara, Tadaaki Kirita and Naohide Oue. Their work appears in journals such as International Journal of Molecular Sciences, Pathobiology, Oncotarget, Cancer Science and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.